Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacteriaceae</i>: A Systematic Review and Meta-Analysis.

Open Forum Infect Dis · 2017 · PMC5499850 · PMID 28702469

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In our analysis, the mortality of patients with ESBL- E coli BSI that were treated with empiric BL/BLIs (18.6 %) was lower compared with the mortality of patients with ESBL- E coli BSI that were treated with empiric carbapenems (26.8%); however, the difference in mortality did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.